相关产品推荐更多 >

TBL1X抗体TBL1X兔多抗抗体X-linked antibody抗体TBL1X Antibody, FITC conjugated抗体
¥880
TMEM98抗体TMEM98兔多抗抗体Protein TADA1 antibody抗体TMEM98 Antibody抗体
¥440
PFAS抗体PFAS兔多抗抗体Formylglycinamide ribotide amidotransferase antibody抗体PFAS Antibody, FITC conjugated抗体
¥880
CPED1抗体CPED1一抗抗体UNQ9432/PRO34713Cadherin-like and PC-esterase domain-containing protein 1 antibody抗体CPED1 Antibody抗体
¥3900
DSCC1抗体DSCC1兔多抗抗体Sister chromatid cohesion protein DCC1 antibody抗体DSCC1 Antibody, HRP conjugated抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human Natural cytotoxicity triggering receptor 3 protein (19-135AA)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
Non-conjugated
- 适应物种:
Human
- 保质期:
6个月
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
O14931
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200
- 浓度:
>95%,Protein G purified
- 靶点:
NCR3
- 抗体英文名:
NCR3 Antibody
- 抗体名:
NCR3;1C7;LY117;Natural cytotoxicity triggering receptor 3;Activating natural killer receptor p30;Natural killer cell p30-related protein;NK-p30;NKp30;CD antigen CD337
- 规格:
100μg/50μg/20μg
| 规格: | 100μg | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μg | 产品价格: | ¥880.0 |
| 规格: | 20μg | 产品价格: | ¥440.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Cell membrane receptor of natural killer/NK cells that is activated by binding of extracellular ligands including BAG6 and NCR3LG1. Stimulates NK cells cytotoxicity toward neighboring cells producing these ligands. It controls, for instance, NK cells cytotoxicity against tumor cells. Engagement of NCR3 by BAG6 also promotes myeloid dendritic cells (DC) maturation, both through killing DCs that did not acquire a mature phenotype, and inducing the release by NK cells of TNFA and IFNG which promote DC maturation.风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验by doxorubicin, Acta Pharmacologica Sinica, 1995,16(4): 333-337.[8] Xu Y F, Xiong D S, Yang C Z et al. The mutation of anti-CD3 antibody (HIT3a) gene and its expression (抗CD3 抗体HIT3a基因突变及其表达研究),Chin J Hematol(中国血液学杂志),2001,22(5):252-255.[9] Campbell A.M. Fusion
人血小板膜糖蛋白IIbIIIa(GP-IIbIIIa/CD41+CD61)抗体
人血小板膜糖蛋白IIbIIIa(GP-IIbIIIa/CD41+CD61) 抗体 酶联免疫分析试剂盒使用说明书 本试剂仅供研究使用 目的:本试剂盒用于测定人血清,血浆及相关液体样本中血小板膜糖蛋白IIbIIIa(GP-IIbIIIa/CD41+CD61) 抗体 的含量。 实验原理: 本试剂盒应用双抗原夹心法测定标本中人血小板膜糖蛋白 IIbIIIa(GP-IIbIIIa/CD41+CD61) 抗体
是通过直接或间接地影响到该细胞的bcl-2的表达或功能,进而抑制细胞生长,诱导细胞凋亡,最终得以有效地挟制和杀灭肿瘤,这为抗体可用于联合化疗或降低病人耐药的临床治疗提供了有力的证据。【参考文献】[1]Golay JT,Clark EA,Beverley PC,et al. The CD20 (BP35)antigen is involved in activation of B cell from the G0 to the G1 phase of the cell cycle. J Immunol
技术资料暂无技术资料 索取技术资料





